|
APPL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.78497233555208E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.48270000008577E-08 |
| Normal-vs-Stage3 |
1.34336985979644E-14 |
| Normal-vs-Stage4 |
4.53825865776025E-12 |
| Stage1-vs-Stage2 |
4.606000E-01 |
| Stage1-vs-Stage3 |
3.790800E-01 |
| Stage1-vs-Stage4 |
1.866820E-01 |
| Stage2-vs-Stage3 |
2.099200E-01 |
| Stage2-vs-Stage4 |
9.833700E-02 |
| Stage3-vs-Stage4 |
5.501400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.548272786702E-12 |
| Normal-vs-AfricanAmerican |
2.56440000001579E-06 |
| Normal-vs-Asian |
1.18300036433538E-10 |
| Caucasian-vs-AfricanAmerican |
5.118000E-01 |
| Caucasian-vs-Asian |
9.711600E-01 |
| AfricanAmerican-vs-Asian |
5.182600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.32907051820075E-15 |
| Normal-vs-Female |
7.91511300946013E-12 |
| Male-vs-Female |
5.849400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.64701585703142E-12 |
| Normal-vs-Age(41-60Yrs) |
1.82731607623055E-12 |
| Normal-vs-Age(61-80Yrs) |
3.43940431690726E-11 |
| Normal-vs-Age(81-100Yrs) |
1.515530E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.162800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.117000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.504200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.401200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.416000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.808600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.956960E-01 |
| Classical-VS-Follicular |
9.374200E-01 |
| Classical-VS-Other |
3.313400E-01 |
| Classical-VS-Normal |
1.00449981665918E-10 |
| Tall-VS-Follicular |
2.059200E-01 |
| Tall-VS-Other |
7.534200E-01 |
| Tall-VS-Normal |
2.02679983907217E-10 |
| Follicular-VS-Other |
4.000800E-01 |
| Follicular-VS-Normal |
2.28870034035822E-10 |
| Other-VS-Normal |
5.596900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.67119659724813E-13 |
| N0-vs-N1 |
5.875600E-02 |
|
|
